Target intelligence / Profile preview

Novel transcript, antisense to CCDC191

Molecular classification: Other (Non-coding RNA, antisense transcript)

Overview

This molecule is an Ensembl-annotated novel RNA transcript (non-coding) that is antisense to the coding sequence of the CCDC191 gene. It does not encode a protein, and its biological significance remains uncharacterized. As an antisense transcript, it could theoretically regulate CCDC191 expression post-transcriptionally, but no functional evidence or characterization exists in major genetic or biomedical databases. No role in disease, drug interaction, or biomarker application has been reported, and it is not recognized as a canonical target in therapeutic development frameworks[1][7].

Other names: ENSG00000285836

Beyond the preview

Go deeper on Novel transcript, antisense to CCDC191.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to CCDC191.

Explore the full profile